Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD -93.30 M

Calumet, Inc. EBITDA is USD -93.30 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -125.46% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 366.40 M, a 56.78% change year over year.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 233.70 M, a 58.01% change year over year.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 147.90 M, a -203.50% change year over year.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -142.90 M, a -172.54% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)